Press Releases

Barry Simms Named as Elligo Health Research’s Chief Operating Officer

Elligo Health Research®, the largest healthcare-enabling research organization, today announced the addition of Barry Simms as Elligo’s Chief Operating Officer (COO). Simms’ expertise in global strategy and partnerships will help further the company’s growth and mission of providing everyone with easy access to participation in research and to accelerate clinical trials along the way.

CD Genomics Launches Mature HLA Typing Solutions Enabling Precision Immune Profiling

Breaking Ground: CD Formulation announces 90+ Active Pharmaceutical Ingredients Lineup

Kiora Pharmaceuticals Granted U.S. and European Patents for Local Ocular Delivery of the KIO-100 Family of Compounds; New IP Specifically Includes Treatment of Posterior Non-Infectious Uveitis

Kiora Pharmaceuticals, a clinical-stage biotechnology company developing products for the treatment of orphan retinal diseases, has been granted U.S. and European Patents for the local ocular delivery of the company’s non-steroidal, anti-inflammatory small molecules covering several inflammatory-related therapeutic applications including posterior non-infectious uveitis – a debilitating autoimmune disease characterized by inflammation of the retina, choroid, vitreous, or optic nerve that can lead to severe vision loss if left untreated.

ACS BrightEdge Poised to Help Improve 1.5 Million Lives By Investing in Cancer-Focused Therapies and Technologies

American Cancer Society's impact venture fund announces annual results and new framework that measures investments' impact on mission to end cancer

Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions

Creative Proteomics Launches Advanced Exosome Isolation and Purification Service

Creative Proteomics Debuts Far-Western Blot Analysis Service to Advance Proteomics Research

Exploring New Frontiers in Drug Delivery: CD Formulation Introduces State-of-the-Art Microsphere and Microneedle Technologies

Alfa Chemistry Launches a New Blog Section: Sharing Chemical Uses, Chemistry Information and News

Katie Coleman promoted to Head of Ashfield Event Experiences US, part of Inizio Engage XD

Biopharma PEG Supplies High Quality Cholesterol (Plant-Derived)

About us Biopharma PEG Scientific Inc. is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity monodispersed and polydispersed polyethylene glycol (PEG) derivatives and PEG raw material, PEGylation services, and custom PEG derivative synthesis to clients worldwide. We continuously expand the capability to provide large-scale manufacture of high purity PEG derivatives with an extensive variety of functional groups, in both non-GMP and GMP grade. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/

HONEYWELL AND RECIPHARM TO SPEED DEVELOPMENT OF INHALERS WITH A NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANT

Partnership to reduce environmental footprint of inhalers

Evoke launches audience intelligence offering to unlock the full commercial potential of life sciences brands

Leading global health and life science brand Evoke has launched a major new audience intelligence service offering to benefit their roster of international pharma and life science clients.

Amerigo Scientific Introduces Water Purification Systems for Life Science Research

Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection

Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

Exothera S.A. has announced that the National Institutes of Health, the US’s medical research agency, has selected them to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.

CD Computabio Unleashes the Power of Computational Biology with Innovative Virtual Screening Service

SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy

SSI Strategy has announced that it has entered into a definitive agreement to acquire NDA Group AB. This strategic combination will create a premier consultancy, specializing in guiding drug development companies from concept to commercialization.

Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies

Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies Accelerating Biotech Success